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This study examined health beliefs associated with novel influenza A (H1N1) immunization among US college undergraduates
during the 2009-2010 pandemic. Undergraduates (ages 18–24 years) from a large Midwestern University were invited to complete
an online survey during March, 2010, five months after H1N1 vaccines became available. Survey items measured H1N1 vaccine
history andH1N1-related attitudes based on the health belief literature. Logistic regression was used to identify attitudes associated
with having received anH1N1 vaccine, and thematic analysis of student comments was conducted to further understand influences
on vaccine decisions. Among the 296 students who participated in the survey, 15.2% reported having received an H1N1 vaccine. In
regression analysis, H1N1 immunization was associated with seasonal flu vaccine history, perceived vaccine effectiveness, perceived
obstacles to vaccination, and vaccine safety concerns. Qualitative results illustrate the relationship of beliefs to vaccine decisions,
particularly in demonstrating that students often held concerns that vaccine could cause H1N1 or side effects. Vaccine safety,
efficacy, and obstacles to immunization were major considerations in deciding whether to accept the H1N1 pandemic vaccine.
Therefore, focusing on those aspects might be especially useful in future vaccine efforts within the college population.
1. Introduction
College students are at especially high risk of contracting and
passing on infectious diseases, due in part to dormitory living
[1] and large social gatherings [2], and influenza is a known
health and academic concern for that population [3]. When
novel influenza A (H1N1) pandemic vaccines were made
available in 2009, young people up to 25 years of age were tar-
geted for vaccination due to their high rate of H1N1 infection
and complications [4]. For these reasons, the Centers for Dis-
ease Control and Prevention [5] and the American College
Health Association [6] issued guidelines for colleges regard-
ing the evolving H1N1 flu pandemic, recommending strate-
gies for containing the epidemic on campuses including faci-
litating student vaccinations.
However, by Fall, 2009, anecdotal reports indicated that
students were choosing to forgo H1N1 vaccination even after
concentrated campus vaccine promotion efforts [7].
Although no definitive data regarding college H1N1 vaccine
acceptance rates are available, several published studies uti-
lizing college samples suggest that protective behaviors,
intentions to be vaccinated and actual H1N1 vaccine uptake
amongUS and international students remained relatively low
throughout the pandemic. In surveys conducted at an
Australian college between June and September of 2009,
76.8% of students reported not having made any changes to
the way they lived due to H1N1 [8]. A Fall, 2009, survey con-
ducted at a US University found that only 15.8% of students
intended to be vaccinated [9]. Similarly, in surveys of college
students in Italy, Israel, and Turkey, less than 25%, 13.9%,
and 7.2%, respectively, reported willingness to be vaccinated
against H1N1 [10–12].
Reports of actual college H1N1 vaccination rates ranged
from 8% among Greek medical students [13] to 12.3% of
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students in a US college [14] and 12.7% of students at an
Indian university [15] By the end of April 2010, only 8%
of students at colleges and universities participating in the
American College Health Association’s Pandemic Influenza
Surveillance program had reportedly been vaccinated [16].
The Health Belief Model [17] provides a framework that
might help explain the low levels of H1N1 vaccination accep-
tance among college students. The model explains a given
protective behavior as resulting from the degree to which an
individual (a) feels susceptible to a condition, (b) perceives
that condition as severe, (c) perceives benefits to taking the
protective action, and (d) perceives few barriers to taking
that action [18]. These four dimensions of health beliefs have
been demonstrated to predict hypothetical and actual vac-
cine acceptance in previous studies [19, 20], although their
relative contribution as predictors has varied across vaccine
types and samples.
In addition to weighing perceived risks and benefits, indi-
viduals often consider the attitudes of other people when
deciding whether to engage in a health protective behavior (a
key element of the Theory of Reasoned Action or TRA) [21].
Therefore, for example, students who believe that getting an
H1N1 vaccine is valued by parents or friends may be more
likely to do become vaccinated, even controlling for their
own personal health beliefs.
Finally, choices regarding protective behaviors (such as
being immunized) could potentially be influenced by per-
ceived efficacy. The Extended Parallel Process Model [22]
asserts that assessing a threat as dangerous results in adaptive
preventative behavior only when accompanied by a belief
that taking action will effectively avoid the danger.
Prior research has demonstrated the association between
college students’ health beliefs and their H1N1 immuniza-
tion intentions. In a sample of students attending college
in Israel during the H1N1 pandemic, Teitler-Regev and col-
leagues [11] found intent to accept H1N1 vaccination to be
associated with, (a) previous seasonal flu shot experience, (b)
high perceived susceptibility, (c) high perceived severity, and
(d) low perceived barriers (conceptualized as a high degree of
risk associated with the H1N1 vaccine). In that study, the
most common reasons for getting vaccinated was to avoid
contracting H1N1, whereas the most common reasons for
rejecting the vaccine was lack of knowledge regarding the
vaccine’s safety and lack of perceived effectiveness. The goal
of the current study was, similarly, to assess the association
between students’ health beliefs and H1N1 vaccine decisions,
but to utilize actual vaccine acceptance (rather than inten-
tion) as the outcome.
Better understanding the relatively low vaccination rates
found among college students during the 2009-2010 pan-
demic involves identifying specific beliefs that were asso-
ciated with declining or accepting H1N1 vaccination. This
information could be vital to clinicians and other health pro-
fessionals hoping to design successful immunization pro-
grams when future pandemics arise. The present study used a
mixed methods approach in order to identify which attitudes
and beliefs were associated with college student’s H1N1
vaccination decisions during the 2009-2010 pandemic.
2. Materials and Methods
Using a concurrent mixed methods research design [23],
quantitative data and qualitative data were collected via the
same online survey. Logistic regression analysis and thematic
content analysis were conducted, with the aim to reach a
degree of convergence between those quantitative and quali-
tative findings in order to allow a more comprehensive per-
spective than either method could produce independently.
2.1. Data Collection. A convenience sample of 296 students
(ages from 18 to 24) was recruited from four large under-
graduate courses taught at a large Midwestern public uni-
versity. The study received university IRB approval, and the
requirement for written informed consent was waived.
Instructors of four survey courses taught within a College of
Human Environmental Sciences provided permission for the
researcher to make a brief announcement regarding the
study. Following the announcement, all students on the
course rosters were sent an e-mail describing the study. Click-
ing on a link within the e-mail message acknowledged con-
sent and led participants to an online survey consisting of
forced-choice items and one open-ended question. To aid
survey response rates, five survey participants were randomly
selected to receive a $50 gift card to the University Bookstore.
In total, 1,171 students were sent an invitation to participate.
A reminder e-mail was sent one week before closing the
survey. All surveys were completed during March, 2010, five
months after H1N1 vaccines were made available to the
public.
2.2. Quantitative Measures
2.2.1. Seasonal Influenza Vaccine History. Students respond-
ed to an itemworded, “Seasonal flu vaccines are offered every
year. How often do you get the annual seasonal flu vaccine?”
Response options were never, seldom, sometimes, almost
every year, and every year.
2.2.2. Beliefs and Attitudes. Based on a review of prior stud-
ies and measures of HBM and TRA constructs [24–27], a 21-
item measure (available from the first author) was created
for use in the study. The measure included 3-item scales for
each of seven constructs, with high scores representing, res-
pectively, high degrees of (a) perceived H1N1 disease sus-
ceptibility, (b) perceived H1N1 disease severity, (c) perceived
efficacy of the H1N1 vaccine, (d) perceived obstacles to get-
ting an H1N1 vaccine, (e) concern regarding the safety of
H1N1 vaccination, (f) general medical dislike, and (g) H1N1
vaccination endorsement from family and friends. Response
options for the 21 items were on a 5-point Likert scale from
“strongly disagree” to “strongly agree.” Exploratory factor
analysis of the 21 items supported a seven-factor solution
with all items loading onto their respective scales as concep-
tualized. Reliability (Chronbach’s alpha) for scales ranged
from .72 to .87, and all scales approximated normal distri-
butions.
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2.3. Quantitative Analysis. Listwise deletion was used in the
regression analysis, resulting in 5 missing cases (1.7%), and
considered acceptable. All analyses were conducted using
PASW statistical software, version 18.0.
A series of univariate logistic regressions were conducted
in order to determine which individual predictors of H1N1
vaccination should be included in a multivariable logistic
regression model. Predictor variables considered were sex,
age, seasonal influenza vaccination history, perceived H1N1
disease susceptibility, perceived H1N1 disease severity, per-
ceived H1N1 vaccine efficacy, perceived H1N1 vaccination
obstacles, H1N1 vaccine safety concerns, general medical
dislike, and H1N1 vaccination endorsement by family and
friends. All predictors with a significance level of P < .10 in
univariate logistic regression were considered for entry into
an adjusted, multivariable model with H1N1 vaccination as
the outcome.
2.4. Qualitative Analysis. Qualitative data were collected on
a single survey item that asked respondents to list any addi-
tional comments about the H1N1 vaccine or the survey. In
analysis, thematic coding was used to generate a set of cate-
gories that best reflected the reasons cited by respondents for
receiving or failing to receive an H1N1 vaccine. The analysis
process involved three steps: (a) identifying all comments
that attempted to explain the rationale behind a respondent’s
H1N1 vaccination decision, (b) establishing a set of thematic
categories that captured ideas in those comments, and (c)
coding all comments into one of the thematic categories.
Comments unrelated to H1N1 decisions were not included
in analysis.
3. Results and Discussion
3.1. Descriptive. A total of 296 respondents who met the
study criteria completed the survey, representing 25.3% of
students to whom an invitation was sent. All participants
who began the survey completed it, with a median comple-
tion time of eight minutes. The sample averaged 19.7 years of
age, with between 12% and 38% of each grade level, fresh-
man through senior, represented. The ethnic distribution
within the sample (87.5% white, 5.4% black, 3% Asian) was
comparable to that found in the college in which data col-
lection took place. However, a higher proportion of females
was present in the sample (87.1%) compared with the college
(71.5%).
Forty-five students (15.2%) reported having received the
H1N1 vaccine. Vaccination rates did not differ significantly
by sex (16.1% of females versus 10.5% of males), χ2 = .800,
df = 1, and P = .371. There was no significant difference in
vaccination rates between the students who self-identified as
white compared with other respondents (16.0% of white ver-
sus 10.8% nonwhite), χ2 = .660, df = 1, and P = .417.
3.2. Regression Results. In univariate regression analysis, var-
iables meeting the P < .10 significance criteria and included
Table 1: Predictors of having received an H1N1 vaccine: final
logistic regression modela.
Variable
Adjusted logistic regression
Odds ratio 95% Confidence
interval
Prior seasonal influenza vaccine
acceptance
1.77∗∗ 1.32–2.38
Perceived H1N1 disease
susceptibility
1.13
Perceived H1N1 disease severity 1.24
Perceived H1N1 vaccine efficacy 2.40∗
1.29–4.45
Perceived obstacles to obtaining
H1N1 vaccine
.36∗ .197–.66
H1N1 vaccine safety concerns .47∗
.29–.77
H1N1 vaccine endorsement of
family and friends
1.01
a
Model contains all variables with significance of P < .10 in univariate
logistic regression.
∗P < .05; ∗∗P < .01.
in the multivariable model were prior seasonal influenza vac-
cination acceptance, perceived H1N1 disease susceptibility,
perceived H1N1 disease severity, perceived H1N1 vaccine
efficacy, perceived obstacles to vaccination, H1N1 vaccine
safety concerns, and H1N1 vaccination endorsement by
family and friends. In multivariable logistic regression after
adjustment to include only variables meeting the established
significance criteria, factors independently associated with
H1N1 vaccine acceptance were (a) prior seasonal influenza
vaccination acceptance, (b) perceived high H1N1 vaccine
efficacy, (c) few perceived obstacles to obtaining an H1N1
vaccine, and (d) few H1N1 vaccine safety concerns (Table 1).
Perceived H1N1 disease susceptibility, severity, and vaccine
endorsement by family and friends were not significant
predictors of H1N1 vaccination in the multivariable logistic
regression analysis.
3.3. Qualitative Results. Approximately one-third of survey
participants (n = 98, 33.1%) chose to write a reply to the
open-ended survey item, resulting in 112 comments provid-
ing reasons to receive or decline an H1N1 vaccine. Almost
without exception, comments focused on reasons to refuse
H1N1 vaccination (rather than reasons to accept). Only three
comments expressed full endorsement of the vaccine (e.g., “I
think the vaccine is a good thing for people to get”).
Table 2 presents thematic categories and representative
comments. The most common comment type expressed
concern over H1N1 vaccine safety. Specifically, students cited
fear of contracting H1N1 disease from the vaccine, experi-
encing side effects from the vaccine, or that immunization
can cause viral mutation into a more virulent strain (e.g., “in
the back of my mind was the theory that antibiotics and
things we do to get rid of or kill viruses/pathogens cause them
to adapt and become more resistant and make themselves
immune to our cures”). Respondents cited a variety of
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Table 2: Qualitative results: influences on H1N1 vaccine decisions.
Category
Number of
responses decisions
Influence on H1N1 vaccine Representative example(s)1
Safety concern 39
Perceived dangers
(direct or indirect)
associated with H1N1 vaccination.
There are countless studies on vaccines being
linked to autism in children and other studies
done that have linked vaccinations to Alzheimer’s.
I believe that vaccinating everyone will provide a
selective pressure for the virus to evolve further.
I have seen a lot of cases with my friends where
they get the vaccine and end up getting the flu
because they are putting a “nonharmful” live
virus into your body.
Severity 17
Beliefs regarding the severity of H1N1
influenza.
For something that is basically an overblown
oversensationalized version of the common flu no
thank you but I do not need a vaccine.
If I get it, I get it. If I do not I do not. I am not
really worried about it at all. Also if I get it, it will
be a good workout for my immune system and I
will just let nature run its course.
Medical dislike 16
General feelings toward medical
procedures or environments.
My sisters and I have always refused taking cough
syrup when my family gave it to us. I think that
had a negative effect about me taking the vaccine.
I hate hate hate (sic) getting shots.
Efficacy 15
Beliefs regarding effectiveness of the
H1N1 vaccine in protecting against
H1N1 influenza.
I believe that most of the H1N1 virus had already
passed through and effected most people by the
time the vaccine arrived.
I most likely would not get this until I knew for
sure that the results 100% provable!
Susceptibility 14
Perceptions of how widespread H1N1 is
or one’s personal likelihood of
contracting H1N1.
I feel my immune system is strong enough that
right now at my age I do not need a flu or H1N1
vaccine.
I do not want the vaccine simply because the
chances of me getting the H1N1 flu are not all that
high as long as I take care of myself and sanitize.
Information 11
Adequacy of knowledge and information
regarding H1N1 and the H1N1 vaccine.
I have not learned enough about the H1N1
vaccine to decide to get it for myself.
My knowledge is limited—as I assume is the case
for many students. Knowledge will influence
whether or not a person is to get vaccinated.
Obstacles 9
Conditions that facilitate or interfere with
obtaining an H1N1 vaccine.
I would only use free preventions.
If it was a nasal spray that was given in our dorms
I would get the vaccine.
History 6
Respondent’s history of receiving
seasonal flu or other vaccines.
I have never had a flu vaccine which is why I did
not have the H1N1 vaccine.
I nor any members in my family have ever gotten
the seasonal flu shot.
Endorsement 5 Advice regarding H1N1 and vaccination.
My father who is a doctor has told me a few times
that it really is not that big of a deal.
1
Spelling and punctuation errors present in respondent quotes have been corrected throughout this paper where they do not interfere with interpretation. No
wording has been modified.
sources for their safety concerns, including the experience of
someone they knew (e.g., “I know of many people actually
getting H1N1 from the nasal mist”), and the Internet (e.g.,
“There are also videos on YouTube of things that go wrong
to people when they get the vaccine”).
In all six of the comments coded as history, respon-
dents reported to have seldom (or never) received seasonal
influenza vaccinations and considered this as an influence on
the decision to refuse H1N1 vaccine (e.g., “I have never got-
ten a flu shot so it would be pointless forme to start now”). In
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comments coded in the susceptibility category, respondents
expressed reasons for feeling unlikely to contract the H1N1
virus, including that she or he was especially healthy (e.g., “I
rarely get sick and I do not feel it is necessary. . .”) and that
H1N1 disease could be avoided though proper hygiene (e.g.,
“The chances of me getting the H1N1 flu aren’t all that high
as long as I take care of myself and sanitize.”). Comments
coded as severity frequently compared disease from H1N1 to
seasonal influenza and minimized the potential severity of
H1N1 disease, (e.g., “I honestly think that H1N1 is not any
different from the flu despite what the media or others might
hype it up to be. I just think they’re sending people into
an unnecessary panic.”). Comments in the efficacy category
included opinions that the H1N1 vaccine had not been
adequately tested, that it was made available too late in the
pandemic to be useful, and that vaccines in general are “just
a guess” or “not fail proof.” Comments labeled obstaclesmen-
tioned mode of administration (injection and nasal mist),
cost, and ease in obtaining the vaccine as factors impacting
their H1N1 vaccination decision (e.g., “I think more people
would get it on campus for free”). Within the medical
dislike category, the most common comments involved
avoidance of injections (e.g., “I’m not too fond of needles and
injections”). In each of the five comments coded as endorse-
ment, respondents cited physician advice not to get the
vaccine (e.g., “When consulting my physician about the
vaccine she did not recommend getting the live vaccination
and was not planning to get it herself”).
One additional category not included in the original
scheme emerged during analysis was termed information.
Eleven respondents claimed that lack adequate information
impacted their decision about H1N1 vaccination. One
student wrote, “The public received precious little fact-based
information and too much of the pro- and anti-vaccination
sides saying “get it” or “no do not get it”. In that kind
of environment it’s easiest just to maintain the status quo.”
The idea that lack of knowledge and uncertainty were reasons
to declining vaccination was a consistent theme in the infor-
mation category.
Comments offered by students who had received an
H1N1 vaccine demonstrate the particular importance of per-
ceived obstacles, vaccine safety and efficacy as influences
weighing on vaccine decisions. Comments among these stu-
dents included opinions that the nasal mist “was much easier
than the shot,” and that the vaccine was “quick and easy.” One
student noted that the vaccine “took less than 5 minutes,”
and another had received a free vaccine but “won’t ever pay to
get theH1N1 vaccine.” Several students who received the vac-
cine still expressed concerns regarding the safety or efficacy of
the vaccine, including the comments “I know many people
actually getting H1N1 from the nasal mist” and “I got the
H1N1 vaccine and became ill after getting it.” One student
expressed that “most of the H1N1 virus had already passed
through . . . by the time the vaccine arrived.” Two students
reported being vaccinated because it was required in their
workplace, and one student indicated that she had accepted a
vaccine because she was diabetic, although she did not con-
sider it effective.
4. Conclusions
Among our sample of 296 US undergraduates, only 15.2%
reported having received an H1N1 vaccine. This finding is
consistent with the relatively low acceptance rates reported
in other studies of U.S. and international college samples [13,
14, 16, 28]. Our multivariable logistic regression and quali-
tative analyses suggest that the low rate of H1N1 vaccination
within our college sample was best explained by a combina-
tion of prior vaccine experience, safety concerns regarding
the vaccine, perceptions of low H1N1 vaccine efficacy, and
perceived obstacles to vaccination. The outcome that prior
seasonal influenza vaccination acceptance predicted H1N1
vaccine acceptance is consistent with results from previous
studies [29]. However, prior acceptance of the seasonal influ-
enza vaccine is not a guarantee of H1N1 vaccine acceptance,
as demonstrated by our finding that of 36 students who
reported getting the annual seasonal flu vaccine every year,
20 (55.6%) had not received an H1N1 vaccine. Recognizing
the relationship between various health beliefs and H1N1
vaccine acceptance is important to develop an understanding
of how future pandemic vaccines might be received.
Unlike previous studies of college students’ acceptance of
vaccines other than H1N1 [19, 20, 27, 30], we did not find
perceived susceptibility to be an independent predictor
of vaccine acceptance when considering additional health
beliefs. Our findings are also in contrast to Teitler-Regev and
colleagues [11] who found susceptibility to predict college
student intentions to accept H1N1 vaccination. Rather, our
findings suggest that variables other than susceptibility were
primary considerations in H1N1 vaccination among our col-
lege student sample. Furthermore, while 83.8% of our res-
pondents agreed that “college students have a high likelihood
of getting infected with the H1N1 virus,” only 37.2% agreed
that, “people like me are likely to get sick with H1N1 influ-
enza.” These findings suggest that optimism bias [31] regard-
ing avoiding the pandemic may have been a factor in some of
our respondents’ vaccination perceptions and decisions.
The beliefs that best explained H1N1 vaccination accep-
tance were related to vaccine efficacy, perceived obstacles to
vaccination, and safety concerns. Results suggest our res-
pondents harbored a high degree of skepticism regarding the
efficacy and safety of the H1N1 vaccine, with less than 20%
of respondents agreeing that “if you get an H1N1 vaccine you
definitely will not get H1N1 influenza,” and a majority
(64.4%) agreeing that “there are probably negative side-
effects to getting the H1N1 vaccine.” Almost half (44.8%) of
our respondents who chose to write a comment cited a safety
concern. These findings are consistent with previous studies
reporting concerns of side effects and perceived ineffective-
ness of the vaccine as reasons for intent to become vaccinated
against H1N1 [11, 12, 14, 32]. In sum, our results suggest
that during the H1N1 pandemic, many college students con-
sidered receiving an H1N1 vaccine to be a risk or inconve-
nience that they were unwilling to accept.
4.1. Limitations. The study is limited by use of a convenience
sample that was heavily skewed toward white females.
Studies of more representative samples of college students are
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necessary before findings can be generalized. This is espe-
cially important given findings of racial and ethnic differ-
ences in health beliefs regarding influenza vaccine decisions
[33, 34]. Regression analyses are limited by the number of
observations in the received vaccination group. Because the
survey was conducted five months after the vaccine became
available, there is a possibility of recall bias regarding vaccine
decisions and influences on those decisions. Further, since
this is a retrospective and correlational study, it is possible
that health beliefs reported by the vaccinated group were
influenced by the process of being vaccinated, rather than
reflecting a prior, causal factor.
4.2. Conclusions. Despite these limitations, the study has
valuable implications for understanding college student res-
ponses to the recent influenza pandemic and for designing
future vaccine programs targeting this population. If the next
pandemic and vaccine are perceived as they were during
the 2009-2010 H1N1 pandemic, low uptake among college
students is likely to be repeated. Our findings suggest that
messages based on increasing susceptibility may be less effe-
ctive than those emphasizing that vaccination is an effective
and safe means of preventing pandemic influenza infection,
and that the H1N1 vaccine cannot cause disease or other
harm. Further, obstacles to H1N1 immunization such as cost
and convenience must be identified and addressed.
The 2009 H1N1 pandemic occurred during an era of
growing public attention to vaccine safety [35]. Because col-
lege students are a group at high risk of acquiring and spread-
ing infectious diseases [36], understanding their immuniza-
tion attitudes and behaviors is an important objective. The
current findings suggest that many college students may have
avoided H1N1 immunization during the 2009-2010 pan-
demic because they considered receiving the vaccine to lack
clear benefits and to involve an unacceptable degree of risk.
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